Partnership Targets $6B Fridge-Free Drug Market
Stablepharma and AFT Pharmaceuticals partner to develop fridge-free injectables for anti-infective and oncology markets. Read about this innovation set to transform global medicine access.
Category : Search result: oncology therapeutics
‘Code Red’: Urgent Call for Ontario to Fix Grey-Bruce Cancer Care
A health coalition declares a ‘code red’ for oncology services in Owen Sound, urging immediate provincial intervention as palliative patients lobby for change. Read the full story.
AHS cancels cancer victory bell at Stollery Children's Hospital
Alberta Health Services ends the tradition of ringing a bell after successful cancer treatment at Edmonton's Stollery Children's Hospital, citing infection control. Critics call the move callous.
Halifax company releases promising cancer study results
A Halifax life sciences company announces groundbreaking cancer treatment study results. Learn about this medical breakthrough and its potential impact on cancer care in Canada.
J&J buys Halda Therapeutics for $3.05 billion
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Page 1 of 1